Filing Details

Accession Number:
0001179110-13-011027
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-28 13:36:03
Reporting Period:
2013-06-25
Filing Date:
2013-06-28
Accepted Time:
2013-06-28 13:36:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232258 Ltd. (Cayman) Investments Healthcare Hbm Centennial Towers, 3Rd Floor
2454 West Bay Road
Grand Cayman E9 00000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-25 280,178 $0.00 280,178 No 4 C Direct
Common Stock Acquisiton 2013-06-25 1,561,317 $0.00 1,841,495 No 4 C Direct
Common Stock Acquisiton 2013-06-25 666,676 $15.00 2,508,171 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series Four Senior Preferred Stock Disposition 2013-06-25 280,178 $0.00 280,178 $0.00
Common Stock Series Five Junior Preferred Stock Disposition 2013-06-25 1,561,317 $0.00 1,561,317 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of issuer's Series Four Senior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's firm commitment underwritten public offerng pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO") and had no expiration date.
  2. Each share of issuer's Series Five Junior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's IPO and had no expiration date.